Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Kreyenbuhl

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Psychiatry|May 1, 2023
An Argument for Antipsychotic PolypharmacyRobert W Buchanan, Julie Kreyenbuhl
Dialogues in Clinical Neuroscience|August 5, 2016
A review of behavioral tailoring strategies for improving medication adherence in serious mental illnessJulie Kreyenbuhl, Elizabeth J Record, Jessica Palmer-Bacon
Schizophrenia Bulletin|June 4, 2009
Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literatureJulie Kreyenbuhl, Ilana R Nossel, Lisa B Dixon
Psychiatric Services (Washington, D.C.)|September 23, 2025
Integrating Cobenfy Into Clinical PracticeYaara Zisman-Ilani, Patricia E Deegan, Julie Kreyenbuhl
Psychiatric Rehabilitation Journal|March 29, 2019
Understanding women veterans' experiences with and management of weight gain from medications for serious mental illness: A qualitative studyJulie Kreyenbuhl, Alicia Lucksted, Katie Despeaux, et al.
Schizophrenia Bulletin|June 6, 2002
The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcomeRobert W Buchanan, Julie Kreyenbuhl, Julie M Zito, et al.
The American Journal of Psychiatry|June 4, 2002
Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophreniaRobert W Buchanan, Julie Kreyenbuhl, Julie M Zito, et al.
Schizophrenia Bulletin|December 4, 2009
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009Julie Kreyenbuhl, Robert W Buchanan, Faith B Dickerson, et al.
Schizophrenia Research|March 21, 2008
Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetesJulie Kreyenbuhl, Deborah R Medoff, Stephen L Seliger, et al.
BMC Psychiatry|October 8, 2025
Implementation strategies to increase tobacco treatment in mental health settings: a systematic reviewCorinne N Kacmarek, Anthony A Vivino, Hannah C Smith, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Psychiatry|May 1, 2023
An Argument for Antipsychotic PolypharmacyRobert W Buchanan, Julie Kreyenbuhl
Dialogues in Clinical Neuroscience|August 5, 2016
A review of behavioral tailoring strategies for improving medication adherence in serious mental illnessJulie Kreyenbuhl, Elizabeth J Record, Jessica Palmer-Bacon
Schizophrenia Bulletin|June 4, 2009
Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literatureJulie Kreyenbuhl, Ilana R Nossel, Lisa B Dixon
Psychiatric Services (Washington, D.C.)|September 23, 2025
Integrating Cobenfy Into Clinical PracticeYaara Zisman-Ilani, Patricia E Deegan, Julie Kreyenbuhl
Psychiatric Rehabilitation Journal|March 29, 2019
Understanding women veterans' experiences with and management of weight gain from medications for serious mental illness: A qualitative studyJulie Kreyenbuhl, Alicia Lucksted, Katie Despeaux, et al.
Schizophrenia Bulletin|June 6, 2002
The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcomeRobert W Buchanan, Julie Kreyenbuhl, Julie M Zito, et al.
The American Journal of Psychiatry|June 4, 2002
Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophreniaRobert W Buchanan, Julie Kreyenbuhl, Julie M Zito, et al.
Schizophrenia Bulletin|December 4, 2009
The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009Julie Kreyenbuhl, Robert W Buchanan, Faith B Dickerson, et al.
Schizophrenia Research|March 21, 2008
Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetesJulie Kreyenbuhl, Deborah R Medoff, Stephen L Seliger, et al.
BMC Psychiatry|October 8, 2025
Implementation strategies to increase tobacco treatment in mental health settings: a systematic reviewCorinne N Kacmarek, Anthony A Vivino, Hannah C Smith, et al.
Pageof 9